Package 21130-295-36

{"route": ["ORAL"], "spl_id": "304fca65-2868-c963-e063-6394a90a183f", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0321130781844"], "unii": ["R16CO5Y76E"], "rxcui": ["2606079"], "spl_set_id": ["304fca65-2867-c963-e063-6394a90a183f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Safeway Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "18 POUCH in 1 CARTON (21130-295-36)  / 2 TABLET, EFFERVESCENT in 1 POUCH", "package_ndc": "21130-295-36", "marketing_start_date": "20240702"}], "brand_name": "Signature Select Effervescent Pain Relief", "product_id": "21130-295_304fca65-2868-c963-e063-6394a90a183f", "dosage_form": "TABLET, EFFERVESCENT", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "21130-295", "generic_name": "aspirin", "labeler_name": "Safeway Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Signature Select Effervescent Pain Relief", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20240702", "listing_expiration_date": "20261231"}